Willem Fibbe joined Starfish Innovations in Januari 2020 as the Chief Scientific Officer. His background is in hematology and stem cell research, and for over 15 years he focused on Regenerative Medicine and Cellular Therapies at the LUMC as a Professor in Hematology and stem cell biology. He has been the director of the Stemcell Transplantation program in the department of Hematology of LUMC and the chair of the department of Immunohematology and Blood Transfusion, where he developed an extensive program in cellular therapies. He has been a member of the Commission for Advanced Therapies (CAT) of the European Medicines Agency (EMA) and is currently a member of the Central Committee for Research on Human Subjects in the Netherlands (CCMO).